Heart failure (HF) with preserved ejection fraction (HFpEF) is a global health care problem,
with diagnostic difficulty, limited treatment options and high morbidity and mortality rates …

Background: Catheter ablation (CA) for atrial fibrillation (AF) has been proposed as a means
of improving outcomes among patients with heart failure and reduced ejection fraction …

Aims The impact of atrial fibrillation (AF) ablation in early heart failure with preserved
ejection fraction (HFpEF) is unknown. Our aim was to determine the impact of AF ablation on …

Aims To investigate the association between catheter ablation for atrial fibrillation (AF) and
mortality as well as hospitalization for heart failure (HF) in patients with HF across the …

Catheter ablation improves clinical outcomes in atrial fibrillation (AF) patients with heart
failure (HF) with reduced ejection fraction (HFrEF). However, the role of catheter ablation in …

Aims This study assessed the prognostic implications of mechanical atrial dysfunction in
heart failure with preserved ejection fraction (HFpEF) patients with different stages of atrial …

Background Advances in catheter ablation (CA) for atrial fibrillation (AF) have improved the
prognosis of patients with heart failure (HF) and AF. However, its optimal timing remains to …

Background Catheter ablation (CA) is an effective treatment for patients with atrial fibrillation
(AF). The potential of CA to benefit AF patients with heart failure and preserved ejection …

Atrial fibrillation (AF) and heart failure (HF) are highly prevalent cardiac disorders worldwide,
and both are associated with poor prognosis. The incidence of AF and HF has been …

Aims Patients with heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation
(AF) have worse clinical outcomes than those with sinus rhythm (SR). We aim to investigate …